Hesperos: Funding, Investors & Team (Sep 2026)
Hesperos, Inc. is a leading company in the field of characterizing an individual's biology using Human-on-a-Chip microfluidic systems. Co-founders Michael L. Shuler and James J. Hickman have been key figures in various scientific advancements, including developing organ-on-a-chip constructs and interconnected multi-organ systems. Their goal is to improve toxicology testing and drug discovery by creating pumpless platforms with serum-free cellular mediums that facilitate communication between different organs and utilize computational modeling to assess physiological responses. These responses are measured in neurons, cardiac and muscle tissues, barrier tissues, neuromuscular junctions, as well as liver, pancreas, and other tissues.
Hesperos has raised $2.0M across 1 funding round on record, the most recent an undisclosed round of $2.0M announced in May 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Hesperos Company Profile and Key Stats
Latest funding round on record: May 2024.
Hesperos Funding Rounds
Hesperos Founders and Leadership Team
No contact details are on record for this team yet.
Hesperos Funding Compared to Other Biotechnology Startups
Hesperos' latest round of $2.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Hesperos in Biotechnology and Orlando
Companies Similar to Hesperos
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Hesperos Funding FAQs
What does Hesperos do?
Hesperos, Inc. is a leading company in the field of characterizing an individual's biology using Human-on-a-Chip microfluidic systems. Co-founders Michael L. Shuler and James J. Hickman have been key figures in various scientific advancements, including developing organ-on-a-chip constructs and interconnected multi-organ systems. Their goal is to improve toxicology testing and drug discovery by creating pumpless platforms with serum-free cellular mediums that facilitate communication between different organs and utilize computational modeling to assess physiological responses. These responses are measured in neurons, cardiac and muscle tissues, barrier tissues, neuromuscular junctions, as well as liver, pancreas, and other tissues.
How much funding has Hesperos raised?
Hesperos has raised $2.0M across 1 round on record. The most recent is an undisclosed round of $2.0M announced in May 2024.
When did Hesperos last raise funding?
Hesperos' most recent funding round on record is an undisclosed round of $2.0M, announced in May 2024.
Who founded Hesperos?
FundedIQ lists Christopher E (Founder) at Hesperos.
Where is Hesperos headquartered?
Hesperos is based in Orlando, Florida, United States.
How many employees does Hesperos have?
Hesperos is in the 51-100 employee band.
How does Hesperos' funding compare to other Biotechnology startups?
Hesperos' latest round of $2.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Hesperos Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Hesperos is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.